Prostate Cancer Clinical Trial
— EMUPROOfficial title:
Comparison of Radical Prostatectomy for the Treatment of Prostate Cancer, Performed by Robot-assisted or Standard Laparoscopy or by Laparotomy : a Multicentric Prospective Study.
NCT number | NCT04638088 |
Other study ID # | GCS-ELSAN-0620 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | March 1, 2021 |
Est. completion date | March 1, 2029 |
Verified date | June 2024 |
Source | Elsan |
Contact | Shahnaz KLOUCHE, MD |
Phone | 00331 58 56 41 71 |
klouche[@]elsan.care | |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Minimally invasive surgery has developed widely since the 1980s and has revolutionized the practices of surgeons. In urology, the development of laparoscopy and then robot-assisted surgery has considerably improved the management of pathologies. In France, as in all the countries concerned, the spread of robotic surgery has taken place without prior studies validating this new technology, nor organizational rules in terms of quality and access to care. The report of the Haute Autorité de Santé dated November 2016 underlines the weakness of the methodological quality of studies and meta-analyzes evaluating robot-assisted total prostatectomy compared to other surgical techniques by laparotomy or conventional laparoscopy. It therefore appears important to evaluate in a large study the interest of this technique in order to help the authorities to decide on the real benefit of this technology and to provide reliable answers to the patients.
Status | Recruiting |
Enrollment | 2000 |
Est. completion date | March 1, 2029 |
Est. primary completion date | September 25, 2024 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - patient hospitalized for a planned radical prostatectomy Exclusion Criteria: - Consent refusal from the patient - Patients protected by law (Art.L 1121-5, 1121-6, 1121-8 du Code de la santé publique) - Absence of a French Health Care Insurance coverage |
Country | Name | City | State |
---|---|---|---|
France | Clinique Esquirol Saint Hilaire | Agen | |
France | Clinique Rhône Durance | Avignon | |
France | Hôpital Privé La Châtaigneraie | Beaumont | |
France | Clinique St Vincent | Besançon | |
France | Polyclinique de Franche Comté | Besançon | |
France | Clinique de Saint Augustin | Bordeaux | |
France | Clinique Keraudren - CHPB | Brest | |
France | Centre Médico-Chirurgical Les Cèdres | Brive-la-Gaillarde | |
France | Polyclinique Médipôle Saint-Roch | Cabestany | |
France | Polyclinique du Parc | Caen | |
France | Polyclinique Montréal | Carcassonne | |
France | Pôle Santé République | Clermont-Ferrand | |
France | Hôpital Privé Saint-François | Desertines | |
France | Clinique Cap-d'Or | La Seyne-sur-Mer | |
France | Pôle Santé Sud | Le Mans | |
France | Clinique Emailleurs-Colombier | Limoges | |
France | Polyclinique de Limoges | Limoges | |
France | Clinique Claude Bernard | Metz | |
France | Polyclinique de Gentilly | Nancy | |
France | Clinique Saint-Augustin | Nantes | |
France | Polyclinique Grand Sud | Nîmes | |
France | Polyclinique Les Fleurs | Ollioules | |
France | Polyclinique de Poitiers | Poitiers | |
France | Clinique du Renaison | Roanne | |
France | Clinique Guillaume De Varye | Saint-Doulchard | |
France | Centre clinical | Soyaux | |
France | Clinique de l'Estrée | Stains | |
France | Clinique Ambroise Paré | Toulouse | |
France | Polyclinique Vauban | Valenciennes | |
France | Hôpital privé Océane | Vannes |
Lead Sponsor | Collaborator |
---|---|
Elsan |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Impact of the prostatectomy procedure (robot assisted laparoscopy, conventional laparoscopy and surgical laparotomy) on the urinary function assessed by the EPIC 50 score | Comparison of the prostatectomy performed by robot assisted laparoscopy or conventional laparoscopy and by surgical laparotomy on the urinary function assessed by the EPIC 50 score (Expanded Prostate Cancer Index Composite) | 45 Days after the surgery | |
Secondary | impact of the robot assisted laparoscopy compared to conventional laparoscopy and by surgical laparotomy in radical prostatectomy on the erectile function assessed by the EPIC 50 score | impact of the robot assisted laparoscopy compared to conventional laparoscopy and by surgical laparotomy on the erectile function assessed by he EPIC 50 score (Expanded Prostate Cancer Index Composite) | 45 Days after the surgery | |
Secondary | impact of the robot assisted laparoscopy in prostatectomy on the urinary function assessed by EPIC 50 SCORE | up to 5 years after surgery | ||
Secondary | impact of the robot assisted laparoscopy in prostatectomy on the erectile function assessed by the International Index of Erectile Function (IIEF-5) score | upt to 5 years after the surgery | ||
Secondary | Assessment of the cost effectiveness of the robot assisted procedure in prostatectomy assessed by EQ5d-5L score | Assessment of the cost effectiveness of the robot assisted procedure in prostatectomy assessed by EQ5d-5L score | 12 months | |
Secondary | Occurence of prostatectomy sequelae (urinary incontinence or erectile dysfunction ) | 3 years | ||
Secondary | Occurence of prostatectomy sequelae (urinary incontinence or erectil dysfunction ) | 5 years | ||
Secondary | Prostate Specific Antigen (PSA) level | measures of the level of PSA in a man's blood | up to 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |